Merck, PATH Form Partnership To Fight Causes Of Maternal Mortality
Pharmaceutical company Merck (MSD) announced Monday it has “awarded a grant to PATH, a global health nonprofit, to identify game-changing technologies with the potential to save the lives of women during pregnancy and childbirth in low-resource settings,” according to a Merck press release. Led by scientists from Merck for Mothers, “a new 10-year, half-billion-dollar initiative,” and PATH, the “partnership, valued at $2.5 million and extending through Fall 2012, will integrate private- and public-sector expertise to help evaluate affordable and easy-to-use maternal health technologies that work in resource-poor settings” in order to “address the two leading causes of maternal mortality — post-partum hemorrhage and preeclampsia — as well as family planning,” the release states (12/5).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.